2005•Journal of Inherited Metabolic DiseaseRequires access

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa

S. Wendt, Catharina Whybra, Christoph Kampmann, E. Teichmann, Michael Beck

Abstract

Fabry disease is an inherited lysosomal storage disease caused by deficiency of alpha-galactosidase A. Enzyme replacement therapy for this multisystem progressive disease has been available only since 2001. We here report the first known successful pregnancy of a female patient receiving such therapy.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Enzyme replacement therapy, Fabry disease, Medicine, Pregnancy, Disease, Multisystem disease, Alpha-galactosidase, Lysosomal storage disease